LYP: other treatments
| Therapy . | References . |
|---|---|
| UVA, UVB | 4,6,67,70,84,108,–110 |
| Topical tacrolimus | 67 |
| Isotretinoin (syn-onym: 13-cis-retinoic acid), alone or in combination with IFN-α | 76,92 |
| Bexarotene, topical or systemic | 66,95 |
| Topical imiquimod 5% | 80 |
| IFN-α, IFN-γ | 88,91,93,94 |
| Single-agent chemotherapy | |
| Topical nitrogen mustard | 6,82 |
| Topical carmustine | 13,8 |
| Topical MTX | 79 |
| Topical cytotoxic alkyl phospholipid hexadecyl-phosphocholine | 111 |
| Multiagent chemotherapy | 66,84 |
| Anti-CD30-antibody (SGN30) | 48 |
| RT | 10,12,15,77,84,85,98,99 |
| Antibiotics (tetracyclines, penicillin, erythromycin) | 84,86,89,98,108 |
| Extracorporeal photopheresis | 78,112 |
| Photodynamic therapy | 113 |
| Acyclovir | 114,115 |
| Sulfones | 84 |
| Mistletoe | 116 |
| Therapy . | References . |
|---|---|
| UVA, UVB | 4,6,67,70,84,108,–110 |
| Topical tacrolimus | 67 |
| Isotretinoin (syn-onym: 13-cis-retinoic acid), alone or in combination with IFN-α | 76,92 |
| Bexarotene, topical or systemic | 66,95 |
| Topical imiquimod 5% | 80 |
| IFN-α, IFN-γ | 88,91,93,94 |
| Single-agent chemotherapy | |
| Topical nitrogen mustard | 6,82 |
| Topical carmustine | 13,8 |
| Topical MTX | 79 |
| Topical cytotoxic alkyl phospholipid hexadecyl-phosphocholine | 111 |
| Multiagent chemotherapy | 66,84 |
| Anti-CD30-antibody (SGN30) | 48 |
| RT | 10,12,15,77,84,85,98,99 |
| Antibiotics (tetracyclines, penicillin, erythromycin) | 84,86,89,98,108 |
| Extracorporeal photopheresis | 78,112 |
| Photodynamic therapy | 113 |
| Acyclovir | 114,115 |
| Sulfones | 84 |
| Mistletoe | 116 |